ALS-CSF infusion reduced the locomotor ability in the hTDP-43WT mice by ~40%, whereas the reduction in the locomotor ability of B6WT mice in response to ALS-CSF was ~23% (Figure 1B). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.